Manfred Mitterer

2.2k total citations
58 papers, 1.3k citations indexed

About

Manfred Mitterer is a scholar working on Oncology, Immunology and Hematology. According to data from OpenAlex, Manfred Mitterer has authored 58 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Oncology, 15 papers in Immunology and 12 papers in Hematology. Recurrent topics in Manfred Mitterer's work include Viral-associated cancers and disorders (10 papers), Lymphoma Diagnosis and Treatment (10 papers) and Multiple Myeloma Research and Treatments (7 papers). Manfred Mitterer is often cited by papers focused on Viral-associated cancers and disorders (10 papers), Lymphoma Diagnosis and Treatment (10 papers) and Multiple Myeloma Research and Treatments (7 papers). Manfred Mitterer collaborates with scholars based in Italy, Austria and Germany. Manfred Mitterer's co-authors include Gilbert Spizzo, Dominic Fong, Patrizia Moser, Günther Gastl, Werner Vogetseder, Thomas F. Schulz, Johanna M. Gostner, R. Margreiter, Clara Larcher and Hartwig P. Huemer and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and Neurology.

In The Last Decade

Manfred Mitterer

56 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Manfred Mitterer Italy 21 526 293 284 279 156 58 1.3k
Michael Koenigsmann Germany 20 436 0.8× 405 1.4× 227 0.8× 296 1.1× 70 0.4× 63 1.5k
Ronit Elhasid Israel 22 250 0.5× 406 1.4× 437 1.5× 507 1.8× 139 0.9× 113 1.8k
Serena Bugatti Italy 28 289 0.5× 301 1.0× 258 0.9× 655 2.3× 102 0.7× 89 2.1k
Frances Humby United Kingdom 22 315 0.6× 280 1.0× 354 1.2× 864 3.1× 128 0.8× 60 2.2k
Rosario García‐Vicuña Spain 26 318 0.6× 384 1.3× 358 1.3× 689 2.5× 131 0.8× 120 2.1k
Antonio Manzo Italy 30 599 1.1× 246 0.8× 449 1.6× 1.2k 4.2× 131 0.8× 72 3.0k
Akihiko Yokohama Japan 19 379 0.7× 594 2.0× 333 1.2× 794 2.8× 120 0.8× 135 1.9k
Apostolos Kontzias United States 15 355 0.7× 379 1.3× 295 1.0× 409 1.5× 167 1.1× 31 1.3k
Jochen Heymanns Germany 20 311 0.6× 135 0.5× 114 0.4× 243 0.9× 87 0.6× 63 994
Heikki Julkunen Finland 29 265 0.5× 327 1.1× 218 0.8× 1.1k 4.1× 125 0.8× 88 2.6k

Countries citing papers authored by Manfred Mitterer

Since Specialization
Citations

This map shows the geographic impact of Manfred Mitterer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manfred Mitterer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manfred Mitterer more than expected).

Fields of papers citing papers by Manfred Mitterer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manfred Mitterer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manfred Mitterer. The network helps show where Manfred Mitterer may publish in the future.

Co-authorship network of co-authors of Manfred Mitterer

This figure shows the co-authorship network connecting the top 25 collaborators of Manfred Mitterer. A scholar is included among the top collaborators of Manfred Mitterer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manfred Mitterer. Manfred Mitterer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Mair, Maximilian J., J.M. Berger, Manfred Mitterer, et al.. (2022). Third dose of SARS-CoV-2 vaccination in hemato-oncological patients and health care workers: immune responses and adverse events – a retrospective cohort study. European Journal of Cancer. 165. 184–194. 20 indexed citations
3.
Mair, Maximilian J., et al.. (2020). Clinical outcomes and prognostic factors in patients with multiple myeloma in South Tyrol: a retrospective single-center analysis. Annals of Hematology. 99(5). 1031–1040. 1 indexed citations
4.
5.
6.
Seeber, Andreas, Manfred Mitterer, Eberhard Gunsilius, et al.. (2013). Feasibility of a Multdisciplinary Lung Cancer Videoconference between a Peripheral Hospital and a Comprehensive Cancer Centre. Oncology. 84(3). 186–190. 14 indexed citations
7.
Fong, Dominic, Gilbert Spizzo, Manfred Mitterer, et al.. (2012). Low Expression of Junctional Adhesion Molecule A Is Associated with Metastasis and Poor Survival in Pancreatic Cancer. Annals of Surgical Oncology. 19(13). 4330–4336. 37 indexed citations
8.
Spizzo, Gilbert, et al.. (2011). Interlaboratory Comparison of K-ras Testing by Real-time PCR and RFLP in Colorectal Cancer Samples. Diagnostic Molecular Pathology. 20(2). 90–93. 3 indexed citations
9.
Brüggemann, Norbert, Manfred Mitterer, Ana Djarmati, et al.. (2009). Frequency of heterozygous Parkin mutations in healthy subjects: Need for careful prospective follow-up examination of mutation carriers. Parkinsonism & Related Disorders. 15(6). 425–429. 35 indexed citations
10.
Nardone, Raffaele, Stefan Golaszewski, Francesca Caleri, et al.. (2009). Delayed Oxaliplatin-Induced Sensorimotor Polyneuropathy. Onkologie. 32(5). 10–10. 2 indexed citations
11.
Fong, Dominic, Patrizia Moser, Johanna M. Gostner, et al.. (2008). High expression of TROP2 correlates with poor prognosis in pancreatic cancer. British Journal of Cancer. 99(8). 1290–1295. 186 indexed citations
12.
Steurer, Michael, Gilbert Spizzo, Manfred Mitterer, & Günther Gastl. (2004). Low-Dose Thalidomide for Multiple Myeloma: Interim Analysis of a Compassionate Use Program. Oncology Research and Treatment. 27(2). 150–154. 12 indexed citations
13.
Kropff, Martin, Nicola Lang, Guido Bisping, et al.. (2003). Hyperfractionated cyclophosphamide in combination with pulsed dexamethasone and thalidomide (HyperCDT) in primary refractory or relapsed multiple myeloma. British Journal of Haematology. 122(4). 607–616. 96 indexed citations
14.
Svaldi, Mirija, et al.. (2002). Transient Myeloproliferative Disorder With a CD7+ and CD56+ Myeloid/Natural Killer Cell Precursor Phenotype in a Newborn. Journal of Pediatric Hematology/Oncology. 24(5). 394–396. 1 indexed citations
15.
Mitterer, Manfred, Mirija Svaldi, Fuat Oduncu, et al.. (2001). Peripheral Blood Monoclonal B-Cells Predict the Event Free Survival in Multiple Myeloma. Leukemia & lymphoma. 41(3-4). 387–395. 9 indexed citations
16.
Mitterer, Manfred, Fuat Oduncu, P Fabris, et al.. (1999). The relationship between monoclonal myeloma precursor B cells in the peripheral blood stem cell harvests and the clinical response of multiple myeloma patients. British Journal of Haematology. 106(3). 737–743. 26 indexed citations
17.
Mitterer, Manfred, et al.. (1999). Epstein-Barr virus related hemophagocytic syndrome in a T-cell rich B-cell lymphoma. Annals of Oncology. 10(2). 231–234. 11 indexed citations
18.
Larcher, Clara, Cathy McQuain, Christoph Berger, et al.. (1997). Epstein-Barr virus-associated persistent polyclonal B-cell lymphocytosis with a distinct 69-base pair deletion in the LMP1 oncogene. Annals of Hematology. 74(1). 23–28. 18 indexed citations
19.
Vogetseder, Werner, Hans G. Feichtinger, Thomas F. Schulz, et al.. (1989). Expression of 7F7‐antigen, a human adhesion molecule identical to intercellular adhesion molecule‐1 (ICAM‐1) in human carcinomas and their stromal fibroblasts. International Journal of Cancer. 43(5). 768–773. 81 indexed citations
20.
Schulz, Thomas F., et al.. (1988). Identification and characterization of a novel membrane activation antigen with wide cellular distribution. European Journal of Immunology. 18(1). 7–11. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael Koenigsmann Breakdown of academic impact, for papers by Ronit Elhasid Breakdown of academic impact, for papers by Serena Bugatti Breakdown of academic impact, for papers by Frances Humby Breakdown of academic impact, for papers by Rosario García‐Vicuña Breakdown of academic impact, for papers by Antonio Manzo Breakdown of academic impact, for papers by Akihiko Yokohama Breakdown of academic impact, for papers by Apostolos Kontzias Breakdown of academic impact, for papers by Jochen Heymanns Breakdown of academic impact, for papers by Heikki Julkunen
Rankless by CCL
2026